These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27460515)

  • 21. Evaluation of the effect of botulinum toxin A on the physical and mental health of patients with hemifacial spasm.
    Wei JS; Hu X; Xia L; Shang J; Han Q; Zhang DY
    Neurologia (Engl Ed); 2024 Sep; 39(7):540-548. PubMed ID: 39232591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Botulinum Toxin for the Treatment of Hemifacial Spasm: An Update on Clinical Studies.
    Tambasco N; Filidei M; Nigro P; Parnetti L; Simoni S
    Toxins (Basel); 2021 Dec; 13(12):. PubMed ID: 34941718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hemifacial spasm].
    Krystkowiak P
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S142-5. PubMed ID: 19576481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemifacial spasm non-motor and motor-related symptoms and their response to botulinum toxin therapy.
    Rudzińska M; Wójcik M; Szczudlik A
    J Neural Transm (Vienna); 2010 Jun; 117(6):765-72. PubMed ID: 20467763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemifacial spasm: results of treatment with low dose botulinum toxin injection.
    Suputtitada A; Phanthumchinda K; Locharernkul C; Suwanwela NC
    J Med Assoc Thai; 2004 Oct; 87(10):1205-11. PubMed ID: 15560699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapy of Hemifacial Spasm with Botulinum Toxin: an Update].
    Jost WH; Laskawi R; Palmowski-Wolfe A; Spittau B; Urban PP
    Fortschr Neurol Psychiatr; 2022 Jan; 90(1-02):37-41. PubMed ID: 35021244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hemifacial spasm. Etiology and management].
    Girard B; de Saint Sauveur G; Tatry M; Abdellaoui M; Tassart M
    J Fr Ophtalmol; 2021 Mar; 44(3):382-390. PubMed ID: 33390255
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Botulinum toxin in the treatment of blepharospasm and hemifacial spasm.
    Kenney C; Jankovic J
    J Neural Transm (Vienna); 2008; 115(4):585-91. PubMed ID: 17558461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemifacial spasm is not affected by state of consciousness: a case report.
    Li T; Feng Z; Song C; Liang Z
    Eur J Med Res; 2021 Dec; 26(1):138. PubMed ID: 34876223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Vertebrobasilar abnormalities in patients with hemifacial spasm: MR-angiography findings].
    Montaner J; Alvarez-Sabín J; Rovira A; Molina C; Grivé E; Codina A; Miquel F
    Rev Neurol; 1999 Oct 16-31; 29(8):700-3. PubMed ID: 10560103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemifacial Spasm as Rare Clinical Presentation of Vestibular Schwannomas.
    Liu J; Liu P; Zuo Y; Xu X; Liu H; Du R; Yu Y; Yuan Y
    World Neurosurg; 2018 Aug; 116():e889-e894. PubMed ID: 29852302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How to face the hemifacial spasm: challenges and misconceptions.
    Aktan D; Depierreux F
    Acta Neurol Belg; 2024 Feb; 124(1):17-23. PubMed ID: 37498482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A significant correlation between delayed cure after microvascular decompression and positive response to preoperative anticonvulsant therapy in patients with hemifacial spasm.
    Terasaka S; Asaoka K; Yamaguchi S; Kobayashi H; Motegi H; Houkin K
    Neurosurg Rev; 2016 Oct; 39(4):607-13. PubMed ID: 27235129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increasing the area and varying the dosage of Botulinum toxin a injections for effective treatment of hemifacial spasm.
    Choe WJ; Kim J
    Acta Otolaryngol; 2016 Sep; 136(9):952-5. PubMed ID: 27067535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vertebral artery pexy for microvascular decompression of the facial nerve in the treatment of hemifacial spasm.
    Ferreira M; Walcott BP; Nahed BV; Sekhar LN
    J Neurosurg; 2011 Jun; 114(6):1800-4. PubMed ID: 21275561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical outcome and improvement in quality of life after microvascular decompression for hemifacial spasms: a case series assessment using a validated disease-specific scale.
    Ray DK; Bahgat D; McCartney S; Burchiel KJ
    Stereotact Funct Neurosurg; 2010; 88(6):383-9. PubMed ID: 20948243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating Transient Hemifacial Spasm that Reappears After Microvascular Decompression Specifically Focusing on the Real Culprit Location of Vascular Compression.
    Shin HS; Lee SH; Ko HC; Koh JS
    World Neurosurg; 2017 Feb; 98():774-779. PubMed ID: 27832991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Failed microvascular decompression surgery for hemifacial spasm due to persistent neurovascular compression: an analysis of reoperations.
    Bigder MG; Kaufmann AM
    J Neurosurg; 2016 Jan; 124(1):90-5. PubMed ID: 26295916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microvascular decompression for atypical hemifacial spasm: lessons learned from a retrospective study of 12 cases.
    Liu J; Yuan Y; Fang Y; Zhang L; Xu XL; Liu HJ; Zhang Z; Yu YB
    J Neurosurg; 2016 Feb; 124(2):397-402. PubMed ID: 26339846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Idiopathic hemifacial spasm responsive to zonisamide: a case report.
    Siniscalchi A; Gallelli L; Palleria C; De Sarro G
    Clin Neuropharmacol; 2009; 32(4):230-1. PubMed ID: 19644231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.